NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Total Expenditure History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Expenditure | ₹285 Cr | ₹243 Cr | ₹249 Cr | ₹178 Cr | ₹132 Cr |
What is the latest Total Expenditure of NGL FINECHEM ?
Year | Total Expenditure |
---|---|
Mar2024 | ₹285 Cr |
Mar2023 | ₹243 Cr |
Mar2022 | ₹249 Cr |
Mar2021 | ₹178 Cr |
Mar2020 | ₹132 Cr |
How is Total Expenditure of NGL FINECHEM Trending?
Years | Total Expenditure | % Change | |
---|---|---|---|
Mar2024 | ₹285 Cr | 17.20 | |
Mar2023 | ₹243 Cr | -2.48 | |
Mar2022 | ₹249 Cr | 40.17 | |
Mar2021 | ₹178 Cr | 34.82 | |
Mar2020 | ₹132 Cr | - |
Compare Total Expenditure of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹822.1 Cr | 8.7% | 24.4% | -45.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | 8.7% |
24.4% |
-45.3% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses